PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Reassessing What’s Possible in Early-Stage EGFR-mutant NSCLC: Insights from the Latest Data
Visit https://www.peervoice.com/SBV860 to view the entire programme with slides. After completing “Reassessing What’s Possible in Early-Stage EGFR-mutant NSCLC: Insights from the Latest Data ”, participants will be able to: Discuss recent clinical data on the management of early-stage EGFR-mutant NSCLC; Explain best practices for mutational testing in patients with early-stage EGFR-mutant NSCLC; Develop strategies to improve communication and collaboration among the multidisciplinary team.